Related Experiment Video
Updated: Aug 11, 2026

05:51
A Human Ex Vivo Atherosclerotic Plaque Model to Study Lesion Biology
Published on: May 6, 2014
Update on the pathogenesis of atherosclerosis
1University of Chicago Medical Center, Department of Pathology, Illinois.
The American Journal of Medicine
|July 31, 1991
Summary
Atherosclerosis involves lipid deposition and smooth muscle cell proliferation. Oxidized low-density lipoproteins (LDL) and immune complexes accelerate this process, suggesting antioxidant and immune-modulating therapies for atherosclerosis.
Area of Science:
- Cardiovascular Biology
- Pathogenesis of Atherosclerosis
Background:
- Atherosclerotic plaque comprises deposited lipids, primarily cholesteryl esters and cholesterol from lower-density lipoproteins (LDL, VLDL), and proliferated smooth muscle cells.
- Lipid deposition often precedes smooth muscle cell buildup in artery walls, contributing to plaque formation.
- Research in the 1980s identified various LDL and VLDL forms (e.g., LDL-1, beta-VLDL, Lp(a)) influencing atherosclerosis, alongside endothelial function alterations impacting lipoprotein transport.
Purpose of the Study:
- To review recent advancements in understanding atherosclerosis pathogenesis.
- To highlight the role of specific lipoprotein subclasses and cellular signaling in plaque development.
- To explore the impact of oxidized LDL, antioxidants, and immune complexes on atherogenesis.
Main Methods:
- Review of scientific literature focusing on lipid metabolism, lipoprotein analysis, endothelial function, and cellular proliferation in atherosclerosis.
- Analysis of studies investigating the effects of oxidized LDL and antioxidants on lesion development.
- Examination of research on immune complexes and their association with accelerated atherogenesis.
Main Results:
- Specific LDL and VLDL subclasses are linked to accelerated atherosclerosis and are influenced by diet.
- Platelet-derived growth factor (PDGF) and leukotrienes are implicated in smooth muscle cell proliferation, potentially stimulated by LDL.
- Oxidized LDL and its apolipoprotein B are involved in atherogenesis, with antioxidants showing a suppressive effect.
- Circulating immune complexes accelerate atherogenesis, even without classic risk factors, leading to a distinct form termed 'atheroarteritis'.
Conclusions:
- Atherosclerosis pathogenesis is complex, involving lipid accumulation, smooth muscle cell proliferation, and inflammatory responses.
- Oxidized LDL presents a significant pathway in atherogenesis, responsive to antioxidant intervention.
- Immune complex-mediated processes represent an alternative pathway for accelerated atherosclerosis, highlighting the role of the immune system.
More Related Videos
Related Concept Videos
Inflammation
Overview
Coronary Artery Disease I: Introduction
Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
Coronary Artery Disease II: Pathophysiology
Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...
Atherosclerosis I: Introduction
Atherosclerosis is a progressive disorder characterized by the buildup of plaques on the arterial inner wall, causing them to narrow and harden over time. These plaques comprise lipids, calcium, blood components, carbohydrates, and fibrous tissue. The process primarily affects the intima of large and medium-sized arteries, reducing blood flow in any artery.Etiology and risk factorsThe cause of atherosclerosis is multifactorial, involving a complex interplay among endothelial injury, lipid...
Atherosclerosis III: Management
Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
Peripheral Artery Disease I: Introduction
Peripheral artery disease (PAD) predominantly results from atherosclerosis, which involves the accumulation of fatty deposits, or plaques, within the walls of arteries. This causes them to narrow and harden, significantly reducing blood flow. PAD predominantly affects the legs, particularly the arteries supplying the thighs and calves. In rare cases, it may involve other arteries, including those in the arms.Etiology of PAD:The principal cause of PAD is atherosclerosis, which results from fatty...

